AAAAAA
Results:
1-21
|
Results: 21
Authors:
Smith, JS
Tachibana, I
Passe, SM
Huntley, BK
Borell, TJ
Iturria, N
O'Fallon, JR
Schaefer, PL
Scheithauer, BW
James, CD
Buckner, JC
Jenkins, RB
Citation: Js. Smith et al., PTEN mutation, EGFR amplification, and outcome in patients with anaplasticastrocytoma and glioblastoma multiforme, J NAT CANC, 93(16), 2001, pp. 1246-1256
Authors:
Friedman, JA
Lynch, JJ
Buckner, JC
Scheithauer, BW
Raffel, C
Citation: Ja. Friedman et al., Management of malignant pineal germ cell tumors with residual mature teratoma, NEUROSURGER, 48(3), 2001, pp. 518-522
Authors:
Buckner, JC
Moynihan, TJ
Citation: Jc. Buckner et Tj. Moynihan, The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents, N ENG J MED, 344(9), 2001, pp. 686-686
Authors:
Buckner, JC
Bassuk, EL
Weinreb, LF
Citation: Jc. Buckner et al., Predictors of academic achievement among homeless and low-income housed children, J SCH PSYCH, 39(1), 2001, pp. 45-69
Authors:
Giannini, C
Scheithauer, BW
Weaver, AL
Burger, PC
Kros, JM
Mork, S
Graeber, MB
Bauserman, S
Buckner, JC
Burton, J
Riepe, R
Tazelaar, HD
Nascimento, AG
Crotty, T
Keeney, GL
Pernicone, P
Altermatt, H
Citation: C. Giannini et al., Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading, J NE EXP NE, 60(3), 2001, pp. 248-262
Authors:
Buckner, JC
Schomberg, PJ
McGinnis, WL
Cascino, TL
Scheithauer, BW
O'Fallon, JR
Morton, RF
Kuross, SA
Mailliard, JA
Hatfield, AK
Cole, JT
Steen, PD
Bernath, AM
Citation: Jc. Buckner et al., A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma, CANCER, 92(2), 2001, pp. 420-433
Authors:
Galanis, E
Buckner, JC
Citation: E. Galanis et Jc. Buckner, Chemotherapy of brain tumors, CURR OP NEU, 13(6), 2000, pp. 619-625
Authors:
Burch, PA
Breen, JK
Buckner, JC
Gastineau, DA
Kaur, JA
Laus, RL
Padley, DJ
Peshwa, MV
Pitot, HC
Richardson, RL
Smits, BJ
Sopapan, P
Strang, G
Valone, FH
Vuk-Pavlovic, S
Citation: Pa. Burch et al., Priming tissue-specific cellular immunity in a phase I trial of autologousdendritic cells for prostate cancer, CLIN CANC R, 6(6), 2000, pp. 2175-2182
Authors:
Burch, PA
Bernath, AM
Cascino, TL
Scheithauer, BW
Novotny, P
Nair, S
Buckner, JC
Pfeifle, DM
Kugler, JW
Tschetter, LK
Citation: Pa. Burch et al., A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas, INV NEW DR, 18(3), 2000, pp. 275-280
Authors:
Rajkumar, SV
Reid, JM
Novotny, PJ
Safgren, SL
Scheithauer, BW
Johnson, PS
Nair, S
Morton, RF
Hatfield, AK
Krook, JE
Ames, MM
Buckner, JC
Citation: Sv. Rajkumar et al., A randomized phase II and pharmacokinetic study of dacarbazine in patientswith recurrent glioma, J NEURO-ONC, 49(3), 2000, pp. 255-261
Authors:
Galanis, E
Buckner, JC
Novotny, P
Morton, RF
McGinnis, WL
Dinapoli, R
Schomberg, P
O'Fallon, JR
Citation: E. Galanis et al., Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas, J NEUROSURG, 93(2), 2000, pp. 201-207
Authors:
James, CD
Galanis, E
Frederick, L
Kimmel, DW
Cunningham, JM
Atherton-Skaff, PJ
O'Fallon, JR
Jenkins, RB
Buckner, JC
Hunter, SB
Olson, JJ
Scheithauer, BW
Citation: Cd. James et al., Tumor suppressor gene alterations in malignant gliomas: Histopathological associations and prognostic evaluation, INT J ONCOL, 15(3), 1999, pp. 547-553
Authors:
Buckner, JC
Peethambaram, PP
Smithson, WA
Groover, RV
Schomberg, PJ
Kimmel, DW
Raffel, C
O'Fallon, JR
Neglia, J
Shaw, EG
Citation: Jc. Buckner et al., Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors, J CL ONCOL, 17(3), 1999, pp. 933-940
Authors:
Prados, MD
Scott, C
Sandler, H
Buckner, JC
Phillips, T
Schultz, C
Urtasun, R
Davis, R
Gutin, P
Cascino, TL
Greenberg, HS
Curran, WJ
Citation: Md. Prados et al., A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: A preliminary report of RTOG 9404, INT J RAD O, 45(5), 1999, pp. 1109-1115
Authors:
Gornet, MK
Buckner, JC
Marks, RS
Scheithauer, BW
Erickson, BJ
Citation: Mk. Gornet et al., Chemotherapy for advanced CNS ependymoma, J NEURO-ONC, 45(1), 1999, pp. 61-67
Authors:
Rajkumar, SV
Buckner, JC
Schomberg, PJ
Pitot, HC
Ingle, JN
Cascino, TL
Citation: Sv. Rajkumar et al., Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas, NEUROSURGER, 44(1), 1999, pp. 67-73
Authors:
Buckner, JC
Reid, J
Malkin, M
Citation: Jc. Buckner et al., Efficacy of antineoplastons A10 and AS2-1 - Reply, MAYO CLIN P, 74(6), 1999, pp. 641-642
Authors:
Buckner, JC
Malkin, MG
Reed, E
Cascino, TL
Reid, JM
Ames, MM
Tong, WPY
Lim, S
Figg, WD
Citation: Jc. Buckner et al., Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma, MAYO CLIN P, 74(2), 1999, pp. 137-145
Authors:
Buckner, JC
Bassuk, EL
Weinreb, LF
Brooks, MG
Citation: Jc. Buckner et al., Homelessness and its relation to the mental health and behavior of low-income school-age children, DEVEL PSYCH, 35(1), 1999, pp. 246-257
Authors:
Perry, A
Jenkins, RB
O'Fallon, JR
Schaefer, PL
Kimmel, DW
Mahoney, MR
Scheithauer, BW
Smith, SM
Hill, EM
Sebo, TJ
Levitt, R
Krook, J
Tschetter, LK
Morton, RF
Buckner, JC
Citation: A. Perry et al., Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors - An analysis of DNA content (ploidy), cellular proliferation, and p53 expression, CANCER, 86(4), 1999, pp. 672-683
Authors:
Rajkumar, SV
Buckner, JC
Schomberg, PJ
Reid, JM
Bagniewski, PJ
Ames, MM
Cascino, TL
Marks, RS
Citation: Sv. Rajkumar et al., Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma, INT J RAD O, 42(5), 1998, pp. 969-975
Risultati:
1-21
|